BCM
CERE

Boone Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-300,000
Closed -$9.54M 16
2023
Q2
$9.54M Hold
300,000
3.42% 12
2023
Q1
$7.32M Buy
+300,000
New +$7.32M 3.43% 11